Effects of the Chinese patent medicine, Honghua injection, on platelet glycoprotein Tib/Ufa receptors in patients with acute coronary syndrome: A randomized controlled trial

Journal of Chinese Integrative Medicine

Volumn 10, Issue 3, 2012, Pages 318-323

  Zhu, Yan Feng ^a   Luo, Hai Ming ^a   Deng, Zhong Long ^a   Fu, De Yu ^a   Yao, Wang ^a   Dai, Jian ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Acute coronary syndrome; Chinese patent drugs; Coronary disease; P selectin; Platelet glycoprotein GP II b III a complex; Platelet membrane glycoprotein; Randomized controlled trial

Indexed keywords

CARDIOVASCULAR AGENT; FIBRINOGEN RECEPTOR; HERBACEOUS AGENT; HONGHUA; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84863370428     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20120311     Document Type: Article

References (13)

1. Xu DM, Jin Y, Xu WP. Carthamus tinctorius injection in treating stable angina pectoris. Zhongguo Xin Yao Yu Lin Chuang Za Zhi. 2003; 22(1): 13-15. Chinese with abstract in English.
2. Li JJ, Jiang LJ, Hou YL, Liang HF, Zhao ZG. Characteristics of erythrocyte rheology in patients with coronary atherosclerotic heart disease after Honghua injection. Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu. 2007; 11 (20): 3912-3915. Chinese with abstract in English.
3. Xu KL, Fan HC, Shen WY, Huang TQ, Liu LM. Clinical treatment of cerebral infarction by Safflower Injection via carotid artery infusion. Zhong Cheng Yao. 2005; 27(6): 678-681. Chinese with abstract in English.
4. Guo ML, Zhang G, Zhang W, Zhang HM, Su ZW. Determination of safflor yellow A by RP-HPLC and resources quality comparison in Carthamus tinctorius. Zhongguo Zhong Yao Za Zhi. 2006; 31 (15): 12341236. Chinese with abstract in English.
5. Guo ZQ, Cheng Z, Li L, Liu QY, Wu HB, Gu Y. Effect of administration of Safflower yellow injection on the platelet aggregate rate and transforming growth factor-i3i in patients without ST elevation acute myocardial infarction. Lin Chuang Xin Xue Guan Bing Za Zhi. 2010; 26 (8): 591-593. Chinese with abstract in English.
6. Xia YY, Min Y, Sheng YC. The effects of hydroxysafflor yellow A on the formation of thrombus and platelet aggregation in rats. Zhongguo Yao Li Xue Tong Bao. 2005; 21 (11): 1400-1401. Chinese with abstract in English.
7. Rossi F, Rossi E, Pareti FI, Colli S, Tremoli E, Gallo L. In vitro measurement of platelet glycoprotein lib/ie a receptor blockade by abciximab: interindividual variation and increased platelet secretion. Haematologica. 2001; 86(2): 192-198.
8. Wang JY. Internal medicine. Beijing: People's Medical Publishing House. 2005: 276-278. Chinese.
9. Evaluation criteria for the curative effects of angina pectoris due to coronary heart disease and electrocardiographic manifestation (Passed by the Symposium on Treatment of Angina Pectoris of Coronary Heart Disease and Arrhythmia, 1979, Shanghai). Zhongguo Yao Shi. 1987; 1(1): 71. Chinese.
10. Xu JF, Chen GF, Li ZL, Chen H. Antiplatelet and anticoagulant therapy for acute coronary syndrome. Yi XueZongShu. 2010; 16(16): 2479-2482. Chinese with abstract in English
11. Li XF, Jiang YR, Gao ZY, Yin HJ, Chen KJ. Screening, identification and analysis of platelet differential functional proteins in patients with coronary heart disease of blood-stasis pattern. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010; 30(5): 467-473. Chinese with abstract in English.
12. EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein- h b/la blockade. Lancet. 1998; 52(9122): 87-92.
13. Maia F, Sd FC, Feres F. Glycoprotein lib/ie a inhibitors in clinical practice. Arq Bras Cardiol. 2009; 92 (1): 6876.